chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt. received PROQUAD and VARIVAX vaccines same day. This was realized after documentation of vaccine administration by PHN. Client was observed for 30 minutes for any adverse reactions per protocol. None noted. PHN called Merck & Co (manufacturer) to discuss potential side effects and things to look for. Injection site soreness, fever, and rash were communicated to mother as side effects to look for. Mother was notified of the incident and of side effects to look for. If any are observed, PHN let mother know to call client's primary health care provider or emergency services as warranted. PHN provided name and phone number to client's mother for follow-up.
Pt called 2 days post vaccination to report redness, swelling, heat and pain at the injection site. Pt states feels systemic itching without rash, no swollen glands.
No adverse reaction to the vaccine, but 6 weeks later I had congestion, cough, headache. I tested at back in October all my test were Negative, it was testing at a vaccination site, and today I tested positive. From last Wednesday I had consistent symptoms with low fever, cough, congestion, headache. I am taking MUCINEX & TYLENOL. I called the doctor, and he will recommend PAXLOVID.
Information has been received from a registered nurse concerning a 42 year old female who (in the past on an unspecified date) was vaccinated with MMR. In September 2006, the patient sought unspecified medical attention and underwent an antibody titer and had a negative mumps antibody. No other information was provided. Additional information has been requested.
This spontaneous report has been received from a Nurse Practitioner who was referring to a infant patient (2 months old at the day of the first adverse event onset) of unknown gender. Information on medical history was not reported. It was reported that on an unknown date the patient received their first dose of RECOMBIVAX HB (# lot not reported) (dose, route not reported)"  at birth, their second dose at 2 months old and 3rd at 4 months old. Information on concomitant therapies was not reported. There was no adverse effect reported. Product Quality Complaint (PQC) was not involved. Additional information has been requested.
general fatigue; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249), via an unspecified route of administration in left arm on 13Jan2021 at 09:15 AM as single for covid-19 immunisation. Medical history included atrial fibrillation (under treatment). The patient had known allergies to penicillin. Concomitant medications included atorvastatin (LIPITOR) 80mg x1 daily; lisinopril (20mg x1 daily) for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. 2 1/2 weeks after first shot on Jan2021, patient experienced general fatigue with continued till 2 shot. The patient did not receive treatment for the event. The outcome of the event was not recovered.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
I have excruciating hip pain which my Dr diagnosed as bursitis of the left hip; I have excruciating hip pain which my Dr diagnosed as bursitis of the left hip; I couldn't walk, sit, or lay on that side; I have had tremendous pain for two weeks only being able to hobble to the bathroom as needed; I'm unable to work at my physical part-time job, and have extreme difficulty sitting for 8 hours for my banking job; It hurts to stand too long; I'm miserable; This is a spontaneous report from a contactable consumer, the patient.   A 70-years-old male patient received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 05Mar2021 at11:15 (at the age of 70 years old);  (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. Medical history included stroke, high blood pressure, overweight. The patient has no known allergies. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN (E.C.)), ; lisinopril (LISINOPRIL); hydrochlorothiazide (HYDROCHLOROTHIAZIDE); atorvastatin (ATORVASTATIN). Facility in which the vaccine was a Public Health Clinic. No other vaccines were given. Since the vaccination the patient had not been tested for COVID-19.  On 06Mar2021 at 18:00 The patient experienced Bursitis, Pain in hip, Unable to walk, Pain, Impaired work ability, Difficulty in standing and Feeling miserable. The events were reported as a disability. The clinical course is as follows The day before, the patient was totally healthy. Day after, I have excruciating hip pain in which the patient's doctor diagnosed as bursitis of the left hip. I couldn't walk, sit, or lay on that side. I have had tremendous pain for two weeks only being able to hobble to the bathroom as needed. Oxycod/Acetamin only barely takes the edge off. The patient was unable to work at his physical part-time job, and have extreme difficulty sitting for 8 hours for his job. It hurts to stand too long. In short, I'm miserable and need help. The adverse events resulted in Physician Office Visit . Treatment given for the events include alternate hot/cold packs, oxycodin/acetamin. The clinical outcome of the events was not recovered.   Information on the lot/batch number has been requested.
Patient's lower lip began swelling about 8:00 PM on Wednesday, 10/15/08. She came to our facility on Thursday morning. We advised her to call her physician, due to large swelling on lower lip. Patient saw M.D. on Thursday, 10/16/08 and was given a benadryl type medication. Swelling was completely gone by Friday morning.
No additional AE/no PQC reported.; Nurse called and reported that a dose of VARIVAX was administered to a patient after a temperature excursion. Caller stated the dose was administered on 10/4/2023 and the product had 1 temperature excursion prior being administered. Caller stated pat; This spontaneous report was received from a nurse, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant medication were not reported.  On 04-OCT-2023, the first dose of varicella virus vaccine live (oka/merck) (VARIVAX)  (lot number W031810 has been verified to be valid, expiration date 05-OCT-2024) (route and anatomical location were not reported) was administered as prophylaxis to a patient after a temperature excursion. Also the vaccine had 1 temperature excursion prior being administered. Caller stated patient had not reported any symptoms.   Moreover it was reported that the temperature: 10F, with yime frame: 1 Hour 15 Minutes 0 Seconds with no previous temperature excursion.
Bald spot on head/lost hair; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 31Aug2021 at 11:00 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history included cinnamon and penicillin allergy (reported as penicillin family). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included birth control and unspecified vitamins; both for an unknown indication from an unknown date and unknown if ongoing. On 03Sep2021 at 09:00, the patient had bald spot on her head and lost hair. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event bald spot on head/lost hair was not resolved at the time of this report.
The patient experience some soreness to the arm and it was difficult to raise his arm. The site has gotten better since then, but still experiencing a little soreness to the area.
chest pain, across bottom of rib cage, pain with deep breathing, Motrin did not help
The morning of February 25, 2021 I received my second COVID vaccine. I was fine until during the night when I tried to get up from the bed to use the bathroom.  My legs became so weak they couldn't hold me up and I was unable to get up from the floor unassisted.  This continued throughout the day for a week or so. Now, more than 2 months later (May 12) I still am having the same issue during the night and early morning. The rest of the day seems to be normal.  This makes me wonder if the vaccine is having an adverse effect on the medications I take at 8pm daily. I have looked on line for clues and interactions but am at a loss. The medications I take at night are Saphris, Ambien, Tegretol, Antabuse, Ingrezza, Trazadone, Thorazine, Klonopin, Chloromozine, and low dose aspirin.  Some of these are generic. I had hoped the problem would resolve itself in time but that doesn?t appear to be the solution.  Please look into this and advise.
30 minutes after the vaccine was administered I got a mild headache that lasted most of the day.  Around 3:30 in the afternoon my wife noticed my left eye being red.  It appeared to be burst blood vessels.  I had not been straining or doing any activity that I believe would have facilitated this type of event.
Malaise at 1400 lightheaded, symptoms persisted until 10 p.m. Symptoms persisted until the next morning, but are improving.
Large tender,swollen,hard,red area surrounding injection site. Antibiotics given in case of infection.
Pt. stated she was light headed and hadn't ate any lunch or had any water. She also reported being anxious. BP 180/100 P78. Pt given a bottle of water and banana and observed for 30 mintues. Dizziness resolved and BP down to 150/80 at discharge.
i got exposed to COVID around end of 2021; i got exposed to COVID around end of 2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01May2021 as dose 1, single (Lot number: EW0176), in left arm and on 22May2021 at 12:00 as dose 2, single (Lot number: EW0179) at the age of 42 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (disability, medically significant), COVID-19 (disability, medically significant) all with onset 17Dec2021, outcome "not recovered" and all described as "i got exposed to COVID around end of 2021". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Dec2021) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. patient did not receive any other medications within 2 weeks of COVID vaccine.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200650035 similar report from same reporter
Supraclavicular lymph nodes swollen to marble sized and painful to the touch: started after 1st shot, more painful and enlarged after 2nd shot; continuing for multiple days after each   Muscle and joint pain: after 1st shot, continuing to 2nd shot and for days after the 2nd shot   Extreme sleepiness: 8 hours after 2nd shot  Headaches: starting the day after the 2nd shot, continuing days later
pt recvd vax;exp sore arm same day as vax; felt irritable & "flip floppy"; 1 wk later;rash on neck,shoulders,hair,arms & itchy all over;8 days later eye became pink & stuffy; saw MD who said flu shot rxn;
Patient presented to Urgent Care at approx 1040 AM on 10/24/21 w/throat swelling, dizziness, HA, OP, unable to speak. Pt reports he received Pfizer booster and influenza vaccine on 10/23/21 and has noticed these symptoms x2 hrs was diagnosed w/anaphylaxis by myself based on exam. Epi & solumedrol were administered in office & pt was transported via EMS to ER.
Facial hives, itching. Treated with 12.5 mg BENADRYL PO.
severe headache for three days; head especially hurts when I bend over or cough; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache for three days) and HEADACHE (head especially hurts when I bend over or cough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe headache for three days) and HEADACHE (head especially hurts when I bend over or cough). At the time of the report, HEADACHE (severe headache for three days) and HEADACHE (head especially hurts when I bend over or cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-May-2021: No new information
Itchiness  at vaccination site 4 hours after injection Fatigue- lasted 4 days Fever- lasted 48 hrs  Chills- lasted 48 hrs  Joint pain that lasted a week
This spontaneous report been received from a registered nurse and referred to a patient of an unknown age and gender. The patient's relevant medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (strength, dose, frequency, route of administration, lot number and expiration date were not reported) for prophylaxis; Then, on unknown dates, the patient received the second and third dose of GARDASIL (strength, dose, frequency, route of administration, lot number and expiration date were not reported). Subsequently, on unknown dates, the patient was vaccinated with an unknown number of doses of GARDASIL 9. There were no adverse effects reported. Additional information is not expected as the reporter did not consent for further follow up.
The Pt  started she felt dizzy about 10 minutes after receiving the Moderna Booster Vaccine. Pt was taken into the room to lie down. Pt told us she already felt a little bit dizzy before receiving the vaccine and that she felt the same reaction with her first 2 doses.   Pt also said that the medication she takes for the attacks makes her dizzy.   Vitals were taken at 11:35 am 131/82 Pulse:64   The patient received water; she drinks like 6 Oz of water.   She was checked by  Md at 11: 40 am. She asked the Pt what symptoms she had, check the numbers on virials.  and check the lungs.   The provider recommended that she wait another 15minutes and she can leave this if she feels better and was no longer dizzy.   The provider came back at 11:58 am to check the Pt, she says she feels better, she was able to get up on her own and was checked by the provider before leaving. Advised her call to clinic id dizziness returned or call all if trouble breathing/ symptom worsens.   we took the vitals 125/82 and pulse 55 pulses the Pt left at 12:02 Pm.
patient states that sometime after vaccine she developed pain in her upper left arm, described as throbbing, sometimes wakes her at night; also has limited range of motion, can not raise left arm above shoulder
This case was reported by a other health professional via call center representative and described the occurrence of injection site discomfort in a elderly male patient who received SHINGRIX for prophylaxis. In June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, less than a year after receiving SHINGRIX, the patient experienced injection site discomfort. On an unknown date, the outcome of the injection site discomfort was recovered/resolved. It was unknown if the reporter considered the injection site discomfort to be related to SHINGRIX. Additional details reported as follows: The caller was GlaxoSmithKline employee from R and D that was made aware of two individuals who received SHINGRIX. The employee reported he first heard of these events this week. Employee would reach out for additional info and encourage consumer to call. This case has been linked with US2018144842 and US2018144839, reported by same reporter and linked with case US2018GSK151216 (reported for same patient for 2nd dose).
BODY ACHES; STOMACH CRAMPS; FACIAL SWELLING; MIGRAINE; HEADACHE; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. the patient did not have any drug abuse/illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, stomach cramps, facial swelling, migraine, headache, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from facial swelling, and fever, was recovering from stomach cramps, had not recovered from headache, and body aches, and the outcome of migraine was not reported. This report was non-serious.
4 days after receiving H1N1 IM checked arm pt developed H S purpura - no hematuria in blood ion stool. was doing better-
pt exp mild fever & diarrhea starting 26APR; 1MAY lost appetite & exp extreme diarrhea & drowsiness; 2MAAAY fever 106 & pt taken to hosp, no dx was made pt put on ATB;
Neuropathy: soles my feet burning Started 1.5 days after second dose.  Low grade fever and body aches started 24 hrs after first dose and ended 6-8hrs after it started
Had a Seizure and was transported to hospital by Ambulance, was admitted and kept overnite to run test. Shaking and Unreponsive.
itching on her back/horrible itching on her legs, arms and feet; Severe hives and welts/whelps; really sick with hives; had a bump on her leg and her buttock; felt yucky; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), intramuscular, administered in Left arm on 22Mar2021 14:00 (at the age of 63 year old) as dose 1, single for COVID-19 immunization. Medical history included she has had spider bites in the past and went into anaphylactic reaction. She did have a couple of times where she went to the hospital where she did go into anaphylactic shock but that was many years ago and has high blood pressure, diagnosed many years ago. Patient has family history of heart disease. Also, has Celery allergy and she thinks she had an allergy to Penicillin. Historical vaccine included MMR booster intramuscularly in left arm, 2 weeks prior and had flu vaccines and all sort of vaccines and never had any reactions. Concomitant medication included unspecified high blood pressure medication for 15 years. On 22Mar2021 patient had the first dose. On 23Mar2021, she felt yucky. On 25Mar2021, when she went to bed, she had a bump on her leg and her buttock, where she thought it was a spider bite. On 26Mar2021, in the morning at 3:30 she woke up and was itching on her back; that was severe hives and saw welts in the mirror. She had horrible itching on her legs, arms and feet. She did not go anaphylactic shock. She was just really sick with hives. She took Benadryl and went back to sleep. She had to go to her physician on 27Mar2021 (Friday) and get some Prednisone for it. It was so bad. They were like giant whelps. They were not on face or chest, but were on her lower back, buttocks, legs, stomach arms and feet. She believes it was a reaction from the shot. No relevant lab tests were done. It is improving only because she has been on massive doses of Prednisone and Benadryl. She believes that prednisone was started on 6 and then decreasing each day and took Benadryl as needed. It was reported, she is concerned about the second dose. At the time of report, she is still not 100% but improving. The outcome of the events swelling and feeling abnormal was unknown and of other events was recovering.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a 52 year old female patient with penicillin, sulfa and many antibiotics allergy. On 13-OCT-2014 the patient was vaccinated with ZOSTAVAX (strength, dose and lot # were not reported). Concomitant therapies included ADVAIR and unspecified emergency inhaler. On 13-OCT-2014 (reported as right after receiving the vaccine), the patient experienced adverse experience at the injection site: arm was swollen, red and hot to the touch at the injection site. Even though the patient stated that these adverse experiences had subsided she was still had a lump at the injection site at the time of this report. Then on the night of 22-DEC-2014, the patient started to have symptoms of shingles on her "rear end". The symptom she was experiencing is a "red blistering rash". The patient had not spoken with her physician at the time of this report; however, the patient did speak to her pharmacist about her adverse experiences. The patient was speaking with the pharmacist because she had received the ZOSTAVAX vaccine there. There were no laboratory diagnostics studies performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
blister; This is a spontaneous report from a contactable consumer. A 35-year-old male patient received bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration, administered in Arm Left on 14May2021 08:30 (Batch/Lot Number: EW0168) as UNKNOWN, SINGLE for covid-19 immunisation. The patient's Medical history and concomitant medications were not reported. On 15May2021 10:00 patient experienced blister. No treatment was provided for the event. The outcome for the event was recovered on an unknown date.